Top

Published in:

01-03-2009 | Original Paper

Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy

Authors: M. Baraldi, R. Avallone, L. Corsi, I. Venturini, C. Baraldi, M. L. Zeneroli

Published in: Metabolic Brain Disease | Issue 1/2009

Abstract

Benzodiazepines of natural origin (NBZDs) have been found in human blood and brains as well as in medicinal plants and foods. In plasma and brain tissue there are i.e. diazepam and nordiazepam equal to commercial drugs but there are also other benzodiazepine-like compounds termed “endozepines”, which act as agonists at the benzodiazepine receptors of central type (CBR). A synthetic pathway for the production of NBZDs has not yet been found, but it has been suggested that micro-organisms may synthesize molecules with benzodiazepine-like structures. Hence NBZDs could be of both endogenous and exogenous source and be considered as natural anxyolitic and sedative. Interestingly there are also natural compounds, such as the polypeptide Diazepam Binding Inhibitor (DBI) acting as an “inversive agonist” implicated in fair and panic disorders. It has been suggested that NBZDs may play a role in the pathogenesis of hepatic encephalopathy (HE). Multidirectional studies evaluated NBZDs levels (1) in the blood of normal subjects, of cirrhotic with or without HE and in commercial benzodiazepine consumers; (2) in the blood of cirrhotic treated or not with a non-absorbable antibiotic; (3) in several constituents of our diet. In conclusion, NBZDs increase sometime in cirrhotics with or without HE but they reach concentrations not higher than those found in commercial benzodiazepines consumers. Hence NBZDs must be considered as occasional precipitating factor of HE and benzodiazepine antagonists only symptomatic drugs. The finding that NBZDs may be in part synthesized by intestinal bacterial flora and in part constituent of our diet underlines the importance to feed cirrhotic patients with selected food.

Ahboucha S, Butterworth RF (2005) Role of endogenous benzodiazepine ligands and their GABA-A-associated receptor in hepatic encephalopathy. Met Brain Dis 20:425–437CrossRef

Ahboucha S, Araqi F, Layrargues GP, Butterworth RF (2005) Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain. Neurochem Int 47:58–63PubMedCrossRef

Ahboucha S, Pomier-Layargues G, Mamer O, Butterworth RF (2006) Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem Intern 49:372–378CrossRef

Albrect J, Norenberg MO (2006) Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44:788–794CrossRef

Alho H, Fremeau RT, Tiedge H, Wilcox J, Bovolin P, Brosius J, Roberts JL, Costa E (1988) Diazepam Binding Inhibitor gene expression: location in brain and peripheral tissues of rat. Proc Natl Acad Sci U S A 85:7018–7022PubMedCrossRef

Anholt RRH, Pederson PL, De Souza EB, Snyder SH (1986) The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane. J Biol Chem 261:576–583PubMed

Antkiewicz-Michaluk L, Guidotti A, Krueger KE (1988) Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Mol Pharmacol 34:272–278PubMed

Avallone R, Zanoli P, Corsi L, Cannazza G, Baraldi M (1996) Benzodiazepine-like compounds and GABA in flower heads of Matricaria chamomilla. Phytoter Res 10:177–179

Avallone R, Zeneroli ML, Venturini I, Corsi L, Schreier P, Kleinschnitz M, Ferrarese C, Farina F, Baraldi C, Pecora N, Frigo M, Baraldi M (1998) Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of liver cirrhosis patients with and without encephalopathy. Gut 42:860–867

Avallone R, Corsi L, Zeneroli ML, Baraldi M (2001) Presence of benzodiazepine like molecules in food and their implication in the nutrition of cirrhotic patients. Innov Food Sci Emerg Technol 2:193–198CrossRef

Baktir GA, Fisch HU, Karlaganis G, Minder C, Bircher J (1987) Mechanism of the excessive sedative response of cirrhotics to benzodiazepine: model experiments with triazolam. Hepatology 7:629–638CrossRef

Bansky G, Meier PJ, Riederer E, Walzer H, Ziegler WH, Schmid M (1989) Effects of the benzodiazepine antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97:744–750PubMed

Baraldi M (1990) Supersensitivity of GABA-A receptors in hepatic encephalopathy. Neurochem Res 6:669–671

Baraldi M, Zeneroli ML (1982) Experimental hepatic encephalopathy: changes in the binding of y-aminobutyric acid. Science 16:427–428CrossRef

Baraldi M, Caselgrandi E, Borella P, Zeneroli ML (1983a) Decrease of brain zinc in experimental hepatic encephalopathy. Brain Res 258:170–172CrossRef

Baraldi M, Caselgrandi E, Borella P, Cremonini C, Zeneroli ML (1983b) Zinc content in brain tissues and GABA receptor function in experimental hepatic encephalopathy. In: Zbinden G (ed) Application of behavioural pharmacology in toxicology. Raven, New York, pp 243–250

Baraldi M, Zeneroli ML, Ventura E, Penne A, Pinelli G, Ricci P, Penne A, Pinelli G, Ricci P, Santi M (1984a) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by benzodiazepine antagonist. Clin Sci 67:167–175PubMed

Baraldi M, Pinelli G, Ricci P, Zeneroli ML (1984b) Toxins in hepatic encephalopathy: the role of the synergistic effect of ammonia, mercaptans and short chain fatty acids. Arch Toxicol 7:103–106

Baraldi M, Zeneroli ML, Ventura E, Vezzelli C (1987) An increase in cerebral benzodiazepine receptors induced by a subacute administration of ammonia, mercaptans and short-chain fatty acids in rats. Clin Sci 73:669–671PubMed

Baraldi M, Zeneroli ML, Rothstein JO (1991) Increased presence of benzodiazepine-like compounds in a rat model of hepatic encephalopathy. In: Bengtsson F, Jeppson B (eds) Progress in hepatic encephalopathy. CRC, Miami, pp 155–160

Barbaccia ML, Berkovich A, Guarneri P, Slobodyansky E (1990) DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications. Neurochem Res 15:161–168PubMedCrossRef

Basile AS, Gammal SH, Jones EA, Skolnick P (1989) GABA-A receptor complex in an experimental model of hepatic encephalopathy: evidence far elevated levels of an endogenous benzodiazepine receptor complex ligand. J Neurochem 53:1057–1063PubMedCrossRef

Basile AS, Hughes RD, Harrison PH, Murata Y, Pannell L, Jones EA, Williams R, Skolnick P (1991) Elevated brain concentrations of 1,4benzodiazepines in fulminant hepatic failure. N Engl J Med 325:473–478PubMed

Basile AS, Harrison PM, Hughes RD, Gu ZQ, Pannell L, McKinney A, Jones EA, Williams R (1994a) Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 19:112–121PubMed

Basile AS, Harrison PM, Hughes RD, Gu ZQ, Pannell L, McKinney A, Jones EA (1994b) Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 19:112–121PubMedCrossRef

Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH (1999) Preliminary evidence of low cortical GABA levels in localized 1 H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psych 156:952–954

Braestrup C, Squires RF (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity [³H]diazepam binding. Proc Natl Acad Sci USA 74:3805–3809PubMedCrossRef

Branch RA, Morgan MH, James J, Read AE (1976) Intravenous administration of diazepam in patients with chronic liver disease. Gut 17:975–983PubMedCrossRef

Butterworth RF, Lavoie J, Peterson C (1989) Excitatory amino acids and hepatic encephalopathy. In: Pomier Larargue G, Butterworth RF (eds) Hepatic encephalopathy: pathophysiology and treatment. Humana, Clifton, pp 417–433

Butterworth RF, Tonon MC, Desy L, Giguere JF, Vaudry H, Pelletier G (1991) Increased brain content of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), following portacaval anastomosis in the rat. Peptides 12:119–125PubMedCrossRef

Cortelli P, Avallone R, Baraldi M, Zeneroli ML, Mandrioli J, Corsi L, Riva R, Tinuper P, Lugaresi L, Baruzzi A, Montagna P (2005) Endozepines in recurrent stupor. Sleep Med Rev XX:1–11

Costa E, Guidotti A (1991) Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 49:325–344PubMedCrossRef

Ferenci P, Pappas SC, Munson PJ, Jones EA (1984) Changes in glutamate receptors on synaptic membranes associated with hepatic encephalopathy or hyperammonemia in the rabbit. Hepatology 4:25–29PubMedCrossRef

Ferrarese C, Appollonio I, Bianchi G, Frigo M, Marzorati C, Pecora N, Perego M, Pierpaoli C, Frattola L (1993) Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 18:3–22PubMedCrossRef

Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A (1988) Improvement of hepatic encephalopathy treated with flumazenil. Lancet 1:1392–1394CrossRef

Guidotti A (1991) Role of DBI in brain and its posttranslational processing products in normal and abnormal behaviour. Neuropharmacology 12:1425–1433

Guidotti A, Baraldi M, Costa E (1979) 1,4-Benzodiazepines and gamma-aminobutyric acid: pharmacological and biochemical correlates. Pharmacology 19:267–277PubMedCrossRef

Guidotti A, Forchetti CM, Corda MC, Konke D, Bennett CD, Costa E (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A 80:3531–3535PubMedCrossRef

Gyr K, Meier R, Haussler J, Bouletreau P, Fleig WE, Gatta A, Holstege A, Pomier-Layrargues G, Schalm SW, Groeneweg M, Scollo-Lavizzari G, Ventura E, Zeneroli ML, Williams R, Yoo Y, Amrein R (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal-systemic encephalopathy: a double blind, randomised, placebo controlled multicenter study. Gut 39:319–324PubMedCrossRef

Jalan R, Turjanski N, Taylor-Robinson SD, Koepp MJ, Richardson MP, Wilson JA, Bell JD, Brooks DJ (2000) Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut 46:546–552PubMedCrossRef

King GL, Knox JJ, Oingledine R (1985) Reduction of inhibition by benzodiazepine antagonist, Ro 15-1788, in the rat hippocampal slice. Neuroscience 15:371–378PubMedCrossRef

Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA (2003) Neurosteroid modulation of GABA-A receptors. Prog Neurobiol 71:67–80PubMedCrossRef

Lavoie J, Pomier Layrargues G, Butterworth RF (1990) Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. Hepatology 11:874–882PubMedCrossRef

MacDonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR (1997) Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 26:277–282PubMedCrossRef

Medina JH, Pena C, Piva M, Paladini AC, De Robertis E (1988) Presence of benzodiazepine-like molecules in mammalian brain and milk. Biochem Biophys Res Comm 152:534–539PubMedCrossRef

Medina JH, Pena C, Levi de Stein M, Wolfman C, Paladini AC (1989) Benzodiazepine-like molecules as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Comm 165:547–553PubMedCrossRef

Moroni F, Lombardi G, Moneti G, Cortesini C (1983) The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 40:850–854PubMedCrossRef

Mullen KO, Martin JV, Mendelson WB, Bassett ML, Jones EA (1988) Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy. Lancet 1:457–459PubMedCrossRef

Mullen KD, Szauter KM, Kaminsky-Russ K (1990) Endogenous benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336:81–83PubMedCrossRef

Nayeem N, Green TP, Martin IL, Barnard EA (1994) Quaternary structure of the native GABA-_A receptor determined by electron microscopic image analysis. J Neurochem 62:808–815

Norenberg MD, Itzhak Y, Bender AS (1997) The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv Exp Med Biol 420:95–111PubMed

Oke BO, Suarez-Quian C, Riond J, Ferrero P, Papadopoulos V (1992) Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Mol Cell Endocrinol 87:81–86CrossRef

Olasmaa M, Guidotti A, Costa E, Rothstein JD, Goldman ME, Weber RJ, Paul SM (1989) Endogenous benzodiazepines in hepatic encephalopathy. Lancet 1:491–492PubMedCrossRef

Olasmaa M, Rothstein JD, Guidotti A, Weber RJ, Paul SM, Spector S, Zeneroli ML, Baraldi M, Costa E (1990) Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J Neurochem 55:2015–2023PubMedCrossRef

Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402–409PubMedCrossRef

Payeur R, Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Zealberg J (1992) CSF diazepam binding inhibitor concentrations in panic disorders. Biol Psych 32:712–716CrossRef

Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, O’Amour M, Wells J, Butterworth RF (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo controlled crossover trial. Hepatology 19:32–37PubMed

Rothstein JH, Guidotti A (1993) Endozepines: non-benzodiazepine endogenous allosteric modulators of GABA receptors. In: lzquierdo I, Medina J (ed.) Natural occurring benzodiazepines structure. Ellis Horwood, London, pp. 115–130

Rothstein JD, Mckhann G, Guarnieri P, Barbaccia ML, Guidotti A, Costa E (1989) Cerebrospinal fluid content of diazepam binding inhibitor (DBI) in chronic hepatic encephalopathy. Ann Neurol 26:57–62PubMedCrossRef

Rothstein JO, Garland W, Puia G, Guidotti A, Costa E (1991) The role of endogenous benzodiazepine receptor ligands in physiology and pathology. In: Barnard EA, Costa E (eds) Transmitter amino acid receptors: structures, transduction and models for drug development. Thieme, New York, pp 325–339

Rothstein JO, Garland W, Puia G, Guidotti A, Weber RJ, Costa E (1992a) Purification and characterisation of naturally occurring benzodiazepine receptor ligands in rat and human brain. J Neurochem 58:2102–2115PubMedCrossRef

Rothstein JO, Guidotti A, Costa E (1992b) Release of endogenous benzodiazepine receptor ligands (endozepines) from cultured neurons. Neurosci Lett 143:210–214PubMedCrossRef

Sangameswaran L, De Blas A (1985) Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines. Proc Natl Acad Sci U S A 82:5560–5564PubMedCrossRef

Sangameswaran L, Fales HM, Friedrich P, De Blas AL (1986) Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. Proc Natl Acad Sci U S A 83:9236–9240PubMedCrossRef

Schafer DF, Jones EA (1982) Potential neural mechanisms in the pathogenesis of hepatic encephalopathy. In: Popper H, Schaffner F (eds) Progress in liver diseases vol 7. Grune & Stratton, New York, pp 615–627

Scollo-Lavizzari G, Steinrnann E (1985) Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1:1324CrossRef

Unseld E, Krishna OR, Fischer C, Klotz U (1989) Detection of desmethyldiazepam and diazepam in brain of different species and plants. Biochem Pharmacol 38:2473–2478PubMedCrossRef

Venturini I, Zeneroli ML, Corsi L, Avallone R, Farina F, Alho H, Baraldi C, Ferrarese C, Pecora N, Frigo M, Ardizzone G, Arrigo A, Pellicci BR, Baraldi M (1998) Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci 63:1267–277CrossRef

Verma A, Nye J, Snyder SH (1987) Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci U S A 84:2256–2260PubMedCrossRef

Vicini S, Alho H, Costa E, Mienville JM, Santi MR, Vaccarino FM (1986) Modulation of y-aminobutyric acid-mediated inhibitory synaptic currents in dissociated cortical cell cultures. Proc Natl Acad Sci U S A 83:9269–9273PubMedCrossRef

Wieland HA, Loddens H, Seeburg PH (1992) A single histidine in GABA-_A receptors is essential for benzodiazepine agonist binding. J Biol Chem 267:1426–1429PubMed

Wildmann J (1988) Increase of natural benzodiazepines in wheat and potato during germination. Biochem Bioph Res Comm 157:1436–1443CrossRef

Woods MJ, Zisterer DM, Williams DC (1996) Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. Biochem Pharmacol 51:1283–1292PubMedCrossRef

Zaman SH (1990) Endogenous steroids and pathogenesis of hepatic encephalopathy. Lancet 336:573–574PubMedCrossRef

Zanoli P, Giacobazzi A, Vaccari G, Zeneroli ML, Baraldi M (1991) Up-regulation of peripheral benzodiazepine receptors in brain areas of rats with galactosamine-induced hepatic encephalopathy. In: Bengtsson F, Jeppson B (eds) Progress in hepatic encephalopathy. CRC, Miami, pp 161–168

Zeneroli ML, Iuliano E, Racagni G, Baraldi M (1982a) Metabolism of gamma-aminobutyric add and brain uptake in galactosamine induced hepatic encephalopathy. J Neurochem 33:1219–1222CrossRef

Zeneroli ML, Ventura E, Baraldi M, Penne A, Messori E, Zieve L (1982b) Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide and octanoic acid. Hepatology 2:532–538PubMedCrossRef

Zeneroli ML, Venturini I, Avallone R, Farina F, Corsi L, Ardizzone G, Centanaro M, Arrigo A, Baraldi M (1996) Hepatic encephalopathy in liver transplant recipients precipitated by benzodiazepines present in transfused blood. Transplantation 62:764–767PubMedCrossRef

Zeneroli ML, Venturini I, Stefanelli S, Farina F, Cosenza R, Miglioli L, Minelli E, Amedei R, Ferrieri A, Avallone R, Baraldi M (1997) Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis. Pharmacol Res 35:557–560PubMedCrossRef

Zeneroli ML, Avallone R, Corsi L, Venurini I, Baraldi C, Baraldi M (2005) Management of hepatic encephalopathy: role of rifaximin. Chemotherapy 51:90–105PubMedCrossRef

Zieve L, Doizaki WM, Zieve FJ (1874) Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 83:16–28

Title: Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy
Authors: M. Baraldi
R. Avallone
L. Corsi
I. Venturini
C. Baraldi
M. L. Zeneroli
Publication date: 01-03-2009
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 1/2009
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-008-9111-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy

Interorgan ammonia trafficking in liver disease

Identifying the direct effects of ammonia on the brain

Thiamine deficiency-related brain dysfunction in chronic liver failure

Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathy

Liver transplantation and neurological side effects